Skip to main content
Premium Trial:

Request an Annual Quote

Eppendorf International, Genpathway, Gene Logic


Eppendorf International last week launched its DualChip Human RNAi Side Effect array. The comp-any claims that the two-array gene chip utilizes gene expression analysis to detect side effects caused by RNAi molecules in the cell such as proliferation, differentiation, or apoptosis.

The Hamburg, Germany-based biotech tools company said the array is suited for scientists in the fields of gene functionalization, target identification and validation and lead optimization.

Genpathway last week launched three tools for analyzing gene transcription, gene regulation, and corresponding pathways.

The San Diego-based company said that researchers can use TranscriptionPath to identify and quantitate gene transcription based on DNA/transcription machinery complexes.

Genpathway’s FactorPath can be used for discovery and quantitation of binding by transcription factors and coactivators, and PromoterPath is useful for identification of promoters and enhancers, and quantitation of their use.

Gene Logic last week said it is now providing Microarray Data Generation and Analysis Services for generating gene expression data from customer-provided biological samples, including tissue, cells, blood, and RNA. Gene Logic said the new service was ideal for pharmaceutical, biotechnology, diagnostics, and government researchers involved in drug discovery and development.


The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.